HEPLISAV-B
LIVE

Serial Number

98014161

Owner

Dynavax Technologies Corporation

Attorney

Beth M. Goldman

First Use Date

Feb 12, 2018

Filing Date

May 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

HEPLISAV-B Trademark

Serial Number: 98014161 • Registration: 7437781

HEPLISAV-B is a trademark filed by Dynavax Technologies Corporation on May 25, 2023. The trademark is classified under Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Dynavax Technologies Corporation (41 trademarks)

2929 Seventh Street, Suite 100
Berkeley, CA 947102722

Entity Type: 03

Trademark Details

Filing Date

May 25, 2023

Registration Date

July 9, 2024

First Use Anywhere

February 12, 2018

First Use in Commerce

February 12, 2018

Published for Opposition

April 23, 2024

Goods & Services

Providing medical and other health information to medical professionals in the fields of medicine, health, pharmaceuticals, vaccines, and vaccine adjuvants; Providing medical information, health information and pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; Providing medical, health and pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals via a website; Providing information in the field of the diagnostic, prophylactic and therapeutic properties of pharmaceuticals via a website; Providing patients with information in the fields of medicine, health and pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 9, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 9, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 13, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 13, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 13, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 20, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 20, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 20, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 27, 2023 NWOS
NEW APPLICATION ENTERED
May 29, 2023 NWAP